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Background: The Expanded Programme on Immunisation (EPI) is one of the most powerful and cost-effective
public health programmes to improve child survival. We assessed challenges and enablers for the programme in
South Africa, as we approach the 2015 deadline for the Millennium Development Goals.
Methods: Between September 2009 and September 2010 we requested national and provincial EPI managers in
South Africa to identify key challenges facing EPI, and to propose appropriate solutions. We collated their responses
and searched for systematic reviews on the effectiveness of the proposed solutions; in the Health Systems
Evidence, Cochrane Library, and PubMed electronic databases. We screened the search outputs, selected systematic
reviews, extracted data, and assessed the quality of included reviews (using AMSTAR) and the quality of the
evidence (using GRADE) in duplicate; resolving disagreements by discussion and consensus.
Results: Challenges identified by EPI managers were linked to healthcare workers (insufficient knowledge of
vaccines and immunisation), the public (anti-immunisation rumours and reluctance from parents), and health
system (insufficient financial and human resources). Strategies proposed by managers to overcome the challenges
include training, supervision, and audit and feedback; strengthening advocacy and social mobilisation; and
sustainable EPI funding schemes, respectively. The findings from reliable systematic reviews indicate that interactive
educational meetings, audit and feedback, and supportive supervision improve healthcare worker performance.
Structured and interactive communication tools probably increase parents’ understanding of immunisation; and
reminders and recall, use of community health workers, conditional cash transfers, and mass media interventions
probably increase immunisation coverage. Finally, a national social health insurance scheme is a potential EPI
financing mechanism; however, given the absence of high-quality evidence of effects, its implementation should be
pilot-tested and the impacts and costs rigorously monitored.
Conclusion: In line with the Millennium Development Goals, we have to ensure that our children’s right to health,
development and survival is respected, protected and promoted. EPI is central to this vision. We found numerous
promising strategies for improving EPI performance in South Africa. However, their implementation would need to
be tailored to local circumstances and accompanied by high-quality monitoring and evaluation. The strength of our
approach comes from having a strong framework for interventions before looking for systematic reviews. Without a
framework, we would have been driven by what reviews have been done and what is easily researchable; rather
than the values and preferences of key immunisation stakeholders.* Correspondence: charles.wiysonge@uct.ac.za
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The Expanded Programme on Immunisation (EPI),
which is one of the most powerful and cost-effective
public health programmes to improve child survival [1-
4], was introduced in South Africa in 1974. The
programme, however, remained fragmented because of
the system of apartheid until 1995; when the national
EPI was formed through the unification of all immunisa-
tion services in the country [5]. Since then, there have
been significant advances in immunisation services de-
livery in South Africa, including the introduction of the
hepatitis B virus vaccine and Haemophilusinfluenzae
type b conjugate vaccine into EPI in 1995 and 1999, re-
spectively. In addition, neonatal tetanus elimination was
validated in 2002 and interruption of wild poliovirus
transmission was declared in 2006 [5]. More recently, in
April 2009, South Africa became the first country in Af-
rica to introduce nationwide routine childhood vaccin-
ation against rotavirus and Streptococcus pneumoniae; at
no cost to recipients.
Despite these advances, there is some evidence that
EPI South Africa faces a number of challenges [6-9]. The
vaccination coverage is low (with only two-thirds of chil-
dren estimated to receive the full series of three doses of
the diphtheria-tetanus-pertussis vaccine by one year of
age) [8,10], measles outbreaks are frequent [6,9], and
community knowledge of immunisation is low [7]. In
order to ensure evidence-informed selection and imple-
mentation of effective healthcare interventions [11] that
would overcome existing barriers and reach every child
in South Africa with life-saving vaccines, we conducted
an audit to elicit programme managers’ views of the
challenges facing EPI and potential solutions for these
challenges. Our objectives were: (1) to determine what
EPI programme managers in South Africa consider as
key barriers to effective implementation of the
programme in the country; (2) to determine what EPI
programme managers consider as the best interventions
to overcome the identified barriers; and (3) to conduct a
comprehensive search of peer-reviewed literature, iden-
tify, and synthesise current best evidence on the effect-
iveness of the interventions proposed by the EPI
programme managers.
Methods
South Africa has one national and nine provincial (sub-
national) EPI managers. In September 2009, we sent e-
mails to the national EPI manager and the nine provincial
EPI managers, requesting the managers to identify
key challenges facing EPI. The two questions asked
were:
1. What, in your opinion, are the five key challenges to
childhood immunisation in South Africa (List thechallenges from the most important challenge to the
least important)?
2. What would be the solutions, in your opinion, to
these challenges (Only one solution for each
challenge)?
Eight days after the initial email request, we sent a
follow-up reminder to non-responders. Responses were
collated two weeks later. The findings of this first audit
were presented at a national immunisation conference in
October 2009; which was attended by all key immunisa-
tion stakeholders in South Africa [12]. The conference
agenda included a critical appraisal of vaccines and vac-
cine administration, globally and with specific reference
to South Africa. In June 2010, the two questions were
again sent to all the 10 EPI managers in the country.
The exercise was initially undertaken as a programme
evaluation for management purposes, and therefore no
ethics review board approval was sought. However, only
later we realised that the results could be of interest to a
wider audience. All EPI managers who responded to the
questionnaire provided consent for their responses to be
published. In addition, we obtained the permission of
the South African National Department of Health to
publish the findings. In this paper we present the key
challenges identified by the managers, the key solutions
they proposed, and the findings from systematic reviews
on the effects of the proposed interventions. Each re-
spondent provided five barriers and five corresponding
corrective interventions. In summarising the responses,
we treated the barriers identified (five per manager)
equally without applying any weighting; irrespective of
whether the barriers were identified by the national or
provincial managers, or whether the barrier was classi-
fied by the manager as most important or least import-
ant. We did the same for the proposed interventions
(one per identified barrier).
On 30 November 2010 we searched the Health Sys-
tems Evidence database, the Cochrane Database of Sys-
tematic Reviews, the Database of Abstracts of Reviews of
Effectiveness, and PubMed. One author (CSW) con-
ducted the search using the search strategy shown in
Table 1. We screened the search outputs in the order in
which the databases are listed here, starting with Health
Systems Evidence database and ending with PubMed.
Figure 1 shows a summary of the search and selection
process. When we found more than one systematic re-
view that assessed a particular intervention, we chose
the one that was more comprehensive and/or more re-
cent. Two authors (CSW and MSS) independently
screened the search results, selected relevant systematic
reviews, and assessed the quality of selected reviews
using the AMSTAR tool [13]. In particular, we assessed
whether the authors of the review reported the study
Table 1 Search strategy for identification of eligible
reviews
A. Interventions directed at healthcare workers
Health Systems Evidence:
Health system topic Provider-targeted strategy
Type of synthesis Systematic review OR policy brief
OR systematic review protocol
Type of question Effectiveness
Publication date range 2000 to 2010
Cochrane Database of Systematic Reviews (CDSR):
Search all text (Training OR education OR workshop
OR supervision OR (outreach AND visit*)
OR (audit AND feedback) OR
monitoring) AND (“Immunization”[Mesh]
OR “Vaccination”[Mesh] OR “
Immunization Programs”[Mesh])
Limits None
Database of Abstracts of Reviews of Effectiveness (DARE):
Search all text (Training OR education OR workshop
OR supervision OR (outreach AND visit*)






Search terms (Training OR education OR workshop
OR supervision OR (outreach AND visit*)




Publication date 01 January 2000 to 31 December 2010
Publication type Reviews
B. Interventions directed at parents or communities
Health Systems Evidence:
Health system topic Consumer-directed strategy
Type of synthesis Systematic review OR policy brief OR
systematic review protocol
Type of question Effectiveness
Publication date range 2000 to 2010
Cochrane Database of Systematic Reviews (CDSR):
Search all text (mobiliz* OR mobilis* OR communicat*
OR advoca*) AND (“Immunization”[Mesh]
OR “Vaccination”[Mesh] OR “Immunization
Programs”[Mesh])
Limits None
Records identified through database searching 
(N = 2538) 
Records screened  
(N = 2538) 
Records excluded  
(N = 1781) 
Full-text articles assessed 
for eligibility  




Reviews included  
(N = 10) 
Figure 1 Flow diagram showing the search and selection of
reviews..
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comprehensive enough to avoid publication, language
and indexing biases; undertook duplicate study selection
and data extraction; used reliable criteria to assess the
risk of bias in included studies; reported the characteris-
tics of included studies appropriately; and combined data
from included studies using reliable methods. Based onthese criteria, we concluded whether the review was well
conducted (i.e. reliable) or not. We have only reported
data from reviews that we considered to be reliable. At
each stage, the two authors compared their results and
resolved any disagreements by discussion and consensus.
Finally, we used the GRADE approach [14,15] to as-
sess the quality of the evidence for the effectiveness of
the proposed strategies. This method results in an as-
sessment of the quality of a body of evidence as high,
moderate, low, or very low. High quality evidence im-
plies that “further research is very unlikely to change our
confidence in the estimate of effect”. Moderate quality
evidence means that “further research is likely to have
an important impact on our confidence in the estimate
of effect and may change the estimate”. Evidence is con-
sidered of low quality if “further research is very likely to
have an important impact on our confidence in the esti-
mate of effect and is likely to change the estimate”, and
very low quality if “we have very little confidence in the
effect estimate”. We began the rating of the quality of
evidence with the study design; evidence from systematic
reviews of randomised controlled trials as high-quality
and that from systematic reviews of observational stud-
ies as low-quality. In addition, five reasons led us to
downgrade the quality of evidence from systematic
reviews of randomised controlled trials and three to up-
grade the quality of evidence from systematic reviews of
observational studies. For pooled data from randomised
controlled trials, the factors that led to rating down the
quality of evidence were risk of bias, heterogeneity, in-
directness, imprecision, and publication bias. Regarding
risk of bias, concerns that limited our confidence in the
evidence include lack of allocation concealment, lack of
blinding of outcome assessment, and a large loss to
follow-up. Heterogeneity of effects across studies for
Table 3 Summary of responses from second round
Barrier Frequency
Count Proportion
1. Insufficient knowledge of vaccines and EPI
practices among staff
14 31.1%
2. Staff shortages and high staff turn-over 9 20.0%
3. Financial constraints 8 17.8%
4. Poor communication among stakeholders 6 13.3%
5. Challenges working with the private sector 3 6.7%
6. Resistance from parents and
anti-immunisation rumours
3 6.7%
7. Vaccine stock-outs 2 4.4%
Total 45 100.0%
Table 4 Strategies proposed by EPI managers for
addressing barriers
Barrier Proposed solution
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reduced our confidence in the evidence. Indirectness
refers to differences between the population, interven-
tion, comparison group and outcome of interest to us,
and those included in the relevant reviews e.g. we used
the evidence on strategies for improving patients’ under-
standing of health information as a proxy for evidence
on parents’ understanding of the importance of child-
hood immunisation [16]. For imprecision, if we found
that studies included relatively few participants and few
events and thus had estimates of effects with wide confi-
dence intervals, we rated down the quality of the evi-
dence. Finally, we downgraded the quality of evidence if
there was a high likelihood of publication bias. Further-
more, we upgraded the quality of the evidence if the
pooled estimates revealed a large magnitude of effect, if
we had negligible concerns about confounders, or if
there was a strong dose-response gradient [14].
Results
We received responses from the national EPI manager
and five provincial EPI managers in the first round (giv-
ing a total of 6 x 5 = 30 identified challenges). For the
second round, we received responses from the six EPI
managers who sent responses in the first round plus
three additional provincial managers (i.e. a total of 9 x
5 = 45 challenges). One provincial manager did not re-
spond. Table 2 shows that consolidation of the responses
from the first round revealed the five key EPI challenges
to be (in descending order): insufficient knowledge of
vaccines and immunisation among staff; staff shortages
and high staff turn-over; financial constraints; poor com-
munication among stakeholders (including insufficient
advocacy and insufficient social mobilisation); and sub-
optimal collaboration between the public and private
health sectors. The second round revealed the first four
key challenges to be identical to those of the first round;
as shown in Table 3. Rumours and reluctance from par-
ents, as well as sub-optimal collaboration between the
public and private health sectors occupied fifth position.
The strategies proposed by the EPI managers for
addressing the EPI challenges are highlighted in Table 4.Table 2 Summary of responses from first round
Barrier Frequency
Count Proportion
1. Insufficient knowledge of vaccines and EPI
practices among staff
13 43.3%
2. Financial constraints 7 23.3%
3. Staff shortages and high staff turn-over 7 23.30%
4. Poor communication among stakeholders 2 6.7%
5. Challenges working with the private sector 2 6.7%
Total 30 100.0%For example, the managers proposed training, supportive
supervision, and audit and feedback for addressing the
insufficient knowledge of immunisation issues among
healthcare workers. Through a comprehensive search
and selection process (as shown in Figure 1), we identi-
fied many well-conducted systematic reviews on strat-
egies for improving the performance of healthcare
workers; including educational meetings [17], supportive
supervision or educational outreach i.e. “a personal visit
by a trained person to health workers in their own set-
tings”[18], audit and feedback i.e. “a summary of per-
formance over a specified period of time given in a
verbal or written format”[19], and printed educational
materials [20]. Concerning strategies for strengthening
vaccine advocacy and social mobilisation, we found reli-
able reviews on parent reminder and recall systems [21],
use of community health workers [22], interactive com-
munication tools [16], mass media interventions [23],
and conditional cash transfers i.e. monetary transfers
made to disadvantaged households on the condition that
they comply with some pre-determined requirements in
relation to health care, such as vaccinating their children
[24]. Finally, regarding appropriate EPI funding schemes1 Insufficient knowledge of
vaccines and immunisation
Training, supportive supervision, and
audit and feedback
2 Financial constraints Government should make appropriate
financial arrangements for financing
the EPI
3 Staff shortages and high
staff turn-over
Government should put in place
appropriate strategies for recruitment
and retention of staff
4 Poor communication
among stakeholders
Use best available evidence for vaccine
advocacy and social mobilisation
5. Resistance from parents
and anti-immunisation
rumours
Strengthen social mobilisation and
provide timely evidence-based response
to rumours
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resource constraints, we found a comprehensive system-
atic review on the impacts of using social health insur-
ance schemes to finance health care [25]. We provide a
description of the objectives, type and number of studies
included, participants, settings, interventions, and out-
comes assessed in the included systematic reviews in
Table 5.
The rating of the quality of currently available evidence
on the proposed remedial strategies is shown in Table 6.
There exists high-quality evidence [14] showing that
interactive educational meetings, audit and feedback, and
supportive supervision can improve healthcare worker
performance [17-19]. The evidence on the effectiveness
of passive distribution of printed educational materials
[20] in improving healthcare worker performance is of
low quality. Regarding strategies aimed at increasing
community demand and support for immunisation ser-
vices, moderate-quality evidence shows that parent re-
minder and recall systems [21], use of community health
workers [22], mass media interventions [23], and condi-
tional cash transfers [24] may increase routine immunisa-
tion coverage. There also exists moderate-quality
evidence that structured and interactive communication
tools may increase parents’ understanding of the import-
ance of childhood immunisation [16]. Finally, there cur-
rently exists very low quality evidence showing that a
social health insurance scheme may improve the use of
health services in low and middle-income countries [25].
Discussion
Decision makers in South Africa need to use consider-
able judgement about how best to use limited resources
they have for maintaining and improving the quality of
health care in order to maximise population benefits. In
making such decisions, they need to consider the poten-
tial areas for quality improvement activities, the likely
benefits and costs required to introduce new quality im-
provement interventions, and the likely benefits and
costs as a result of any changes in the behaviour of
healthcare workers. With the values and preferences of
programme managers as a starting point, we found that
the use of interactive educational meetings and work-
shops, audit and feedback, supportive supervision, par-
ent reminder and recall systems, conditional cash
transfers, community health workers, mass media inter-
ventions, and interactive communication tools could be
effective in improving EPI performance in South Africa.
In selecting which combination of interventions to use
for which community and at which time point, decision
makers would need to consider population characteris-
tics, available resources, and competing priorities. A
major strength of our approach comes from having a
framework for interventions (i.e. collating managers’views of the barriers to effective implementation of the
EPI programme and their proposals of effective interven-
tions for addressing these barriers) before looking for
systematic reviews of effects. If we had searched the lit-
erature for effective interventions for improving child-
hood immunisation, without such a framework, we
would have been driven by what systematic reviews have
been done and what is easily researchable; rather than
the priorities of key immunisation stakeholders.
The settings and designs of the studies included in the
systematic reviews that assessed the effects of interactive
educational meetings, audit and feedback, and educa-
tional outreach visits for improving healthcare worker
performance varied widely; but the studies consistently
showed that these strategies can improve healthcare
worker performance [17-19].The reviews also found that
multifaceted interventions may not be any more effective
than educational meetings, outreach visits, or audit and
feedback alone [17-19]. The consistency of effects across
different study designs and healthcare settings and con-
ditions suggests that these findings would be applicable
to the EPI in South Africa. The low quality of the evi-
dence on the effects of passive distribution of printed
educational materials [20] implies that we have limited
confidence in the effectiveness of this strategy to im-
prove the knowledge of vaccine and immunisation issues
among healthcare workers in South Africa [14]. Social
mobilisation for immunisation may include active com-
munity participation, contextualisation of information in
the local customs and culture, and involvement of a
broad range of stakeholders and the mass media. The
moderate quality of the evidence on parent reminder
and recall systems [21], community health workers [22],
interactive communication tools [16], conditional cash
transfers [24], and mass media interventions [23] is an
indication that these strategies could have significant
effects in mobilising communities and increasing de-
mand for routine childhood immunisation services in
South Africa.
Appropriate financing mechanisms are needed to en-
sure that there are sufficient funds (at all times in all
health districts) to recruit and retain a sufficient number
of qualified staff, procure adequate quantities of vac-
cines, purchase and maintain the appropriate vaccine-
related equipment and other logistics; and maintain and
improve the quality of care. Evidence of effects, popula-
tion characteristics, societal values, and attitudes are im-
portant when selecting funding schemes which aim to
ensure universal coverage of health services. Childhood
immunisation services are provided free of charge at
public health facilities in South Africa [5]. Therefore,
sustainable EPI financing mechanisms relevant to the
South African context would include the use of general
tax revenues or a social health insurance scheme to
Table 5 Characteristics of included systematic reviews
Review question / objective Data sources Interventions Data collection and analysis
Reference [16]
What are the most effective
communication tools to improve
patient understanding of
‘evidence’?
Cochrane Library, Medline, Psychinfo, Embase, Cancerlit,
authors’ personal files.
10 SRs and 17 RCTs on tailored print information, decision aids,
consultation summaries or instructions (audiotapes, written and
verbal), provider training in a patient-centred approach with or
without risk communication, video, interactive computer
aids/touch screens, evidence-based leaflets, and question prompts.
Conducted duplicate study selection,
critical appraisal (of RCTs and SRs
using validated checklists) and data
extraction; and narrative synthesis
and meta-analysis, as appropriate.
Last search: June 2004
Reference [17]
Are educational meetings and
workshops effective in improving
professional practice or
healthcare outcomes?
EPOC trials register, EMBASE, reference lists 81 RCTs of educational meetings (alone or as part of multifaceted
interventions); conducted in North America (31 studies),
Europe (34), Australia and New Zealand (4), South East Asia (4),
Latin America (3), and sub-Saharan Africa (4).
Conducted duplicate study selection,
critical appraisal (of RCTs and SRs
using validated checklists) and data
extraction; and narrative synthesis
and meta-analysis, as appropriate.
Last search: March 2006.
Reference [18]
Are educational outreach visits
effective in improving health
professional practice and
healthcare outcomes?
EPOC register, Medline, EMBASE, reference lists 69 RCTs of educational outreach visits (alone or as part of
multifaceted interventions); conducted in North America
(23 RCTs), Europe (36), Australia (8), and South East Asia (3).
Conducted duplicate study selection,
critical appraisal (of RCTs and SRs
using validated checklists) and data
extraction; and narrative synthesis
and meta-analysis, as appropriate.
Last search: March 2007.
Reference [19]
Is audit and feedback effective in
improving professional practice
and health care outcomes?
EPOC register, Medline, EMBASE, reference lists 118 RCTs of audit and feedback (alone or as part of multifaceted
interventions); conducted in North America (67), Europe (30),
Australia (9), South East Asia (3), and sub-Saharan Africa (1).
Conducted duplicate study selection,
critical appraisal (of RCTs and SRs
using validated checklists) and data
extraction; and narrative synthesis
and meta-analysis, as appropriate.
Last search: February 2006
Reference [20]
To determine the effectiveness
of printed educational materials
in improving process outcomes
and patient outcomes.
EPOC register, Medline, EMBASE, CENTRAL, DARE,
CINAHL, CAB Health, reference lists.
12 RCTs, 1 CBA, and 10 ITS of printed educational materials;
conducted in North America (14) and Europe (9).
Conducted duplicate study selection,
critical appraisal (of RCTs and SRs
using validated checklists) and data
extraction; and narrative synthesis
and meta-analysis, as appropriate.





















Table 5 Characteristics of included systematic reviews (Continued)
To assess the overall effectiveness
of patient reminder or recall
systems, or both, in improving
immunisation coverage
EPOC register, Medline, EMBASE, CENTRAL,
PsychINFO, CINAHL, Sociological Abstracts, CAB
Abstracts, reference lists.
40 RCTs and 3CBAs of of patient reminder or recall systems;
conducted in North America (37), Europe (2) and Australia and
New Zealand (4)
Conducted duplicate study selection,
critical appraisal (of RCTs and SRs
using validated checklists) and data
extraction; and narrative synthesis
and meta-analysis, as appropriate.
Last search: May 2007
Reference [22]
To assess the effects of lay health
worker interventions in primary
and community health care on
maternal and child health and
the management of infectious
diseases.
Medline, EMBASE, CENTRAL, PsychINFO, CINAHL,
Sociological Abstracts, CAB Abstracts, British Nursing
Index and Archive, POPLINE, WHOLIS, ISI Web of
Science, Healthstar, reference lists.
82 RCTs on use of lay health worker interventions; conducted in
high-income countries (55), middle-income countries (12), and
low-income countries (15).
Conducted duplicate study selection,
critical appraisal (of RCTs and SRs
using validated checklists) and data
extraction; and narrative synthesis
and meta-analysis, as appropriate.Last search: February 2010
Reference [23]
To assess the effect mass
media interventions on utilisation
of health services.
EPOC register, Medline, EMBASE, Eric, PsycLit, hand
search of relevant journals, reference lists.
20 ITS and 1 CBA of mass media campaigns (using radio,
television, newspapers, posters and leaflets); conducted in
Europe (10), North America (5), Australia (4), and
Latin America (1).
Conducted duplicate study selection,
critical appraisal (of RCTs and SRs
using validated checklists) and data
extraction; and narrative synthesis
and meta-analysis, as appropriate.
Last search: 1999
Reference [24]
To assess the effectiveness of
conditional monetary transfers in
improving access to care and
health outcomes, in particular for
poorer populations in LMICs.
EPOC register, CENTRAL, Medline, EMBASE, Popline,
CAB-Direct, WHOLIS, LILACS, many other databases
and websites/online resources, reference lists.
4 RCTs and 2 CBAs of conditional cash transfer programmes;
conducted in Latin America (5) and sub-Saharan Africa (1).
Conducted duplicate study selection,
critical appraisal (of RCTs and SRs
using validated checklists) and data
extraction; and narrative synthesis
and meta-analysis, as appropriate.
Last search: May 2009.
Reference [25]
To assess the effectiveness of
risk protection mechanisms in
improving access to care in
LMICs
EPOC register, CENTRAL, Medline, EMBASE, Popline,
CAB-Direct, WHOLIS, LILACS, many other databases and
websites/online resources, reference lists.
Authors found few reports of social health insurance schemes
operating at national level in LMICs; but none of these studies
was an RCT, CBA, or ITS.
Duplicate screening of search output
and assessment of potentially eligible
studies for inclusion.
Last search: May 2009.
EPOC Cochrane Effective Practice and Organisation of Care Group, SR systematic review, RCT randomised controlled trial; controlled before-and-after study, ITS interrupted time series analyses, CENTRAL Cochrane




















Table 6 Summary of the quality of evidence
Challenges identified by EPI managers Remedial strategies suggested by EPI managers GRADE quality of evidence*
Insufficient knowledge of vaccines and
immunisation issues among health workers
Regular education High
Supportive supervision/educational outreach High
Audit and feedback High
Printed educational materials. Low
Anti-immunisation rumours and resistance
from parents
Parent reminder and recall systems Moderate
Community health workers Moderate
Mass media Moderate
Structured, tailored, or interactive communication tools Moderate
Conditional cash transfers Moderate
Insufficient financial and human resources Tax-funded financing of immunisation programmes No systematic review of effects
Social health insurance scheme for financing of EPI Low
*GRADE quality of evidence (From reference [15]):
High quality: “We are very confident that the true effect lies close to that of the estimate of the effect”.
Moderate quality: “We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility
that it is substantially different”.
Low quality: “Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect”; Very low quality: “We
have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect”.
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insurance refers to compulsory health insurance that
aims to provide universal coverage. The compulsory na-
ture of social health insurance should reduce adverse se-
lection and enable redistributive mechanisms between
poor and affluent segments of the population. However,
few examples exist of social health insurance schemes
operating at a large scale in low and middle-income
countries; none of which provides strong evidence
related to their impact [25]. The National Health Insur-
ance (NHI), whose planned introduction in the health
sector in South Africa has become a very topical issue, is
a type of social health insurance scheme. The South Af-
rican National Department of Health indicates that the
NHI “is based on the key principles of universality, that
every South African would be entitled to benefit from
the services it covers, and that it would be funded partly
by compulsory contributions by all persons who are
earning an income and partly by tax. All these funds
would be placed in a single pool. This pool would be
available to fund all health care in the public and private
health sector under conditions that would apply to all
health care service providers.” [26].
Our study has some limitations. One provincial man-
ager did not respond to our questions. However, given
the consistency of the key challenges across the other
eight provinces, we do not think that the EPI challenges
in the province of the manager who did not respond
would be substantially different from those of the other
provinces. There is a possibility that the presentation of
findings of the first round to EPI managers may have
influenced the responses in the second round of the
audit. However, this does not seem to have been the case
because new challenges (e.g. reluctance from parents)emerged from the second round. Regardless of these po-
tential shortcomings, we believe that this study is a good
reflection of the challenges encountered in the planning,
delivering, and monitoring of childhood immunisation
services in South Africa. Most of the evidence of effects
described above comes from studies conducted in high-
income countries, and applicability to South Africa or
other low and middle-income countries may be limited.
There is thus a need for high-quality studies from low
and middle-income countries, assessing the effects of
strategies for improving immunisation services. In the
meantime, implementation of such strategies in South
Africa should be pilot-tested and their impacts and costs
rigorously monitored and evaluated [11].
Conclusion
In line with the Millennium Development Goals, we
have to ensure that our children’s right to health, devel-
opment and survival is respected, protected and pro-
moted. EPI is central to this vision. We found numerous
promising strategies for improving EPI performance in
South Africa. However, their implementation would
need to be tailored to local circumstances and accom-
panied by rigorous monitoring and evaluation. The sug-
gested interventions (by EPI programme managers) for
handling immunisation challenges and the availability
(or lack) of sound scientific evidence on their effective-
ness, emphasise the need for partnerships between
health policy makers, programme managers, and
researchers in order to ensure that health decisions are
always informed by the best available evidence [27,28].
Collaboration between the three stakeholders needs to
be continuous, as the results of this audit show that
challenges to immunisation may vary from time to time.
Wiysonge et al. BMC Public Health 2012, 12:578 Page 9 of 9
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are needed to create a health system that is effective,
equitable, and sustainable; one in which EPI will be bet-
ter able to meet its obligations.
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